173 related articles for article (PubMed ID: 8518792)
1. In-frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease.
Bernardi F; Patracchini P; Gemmati D; Pinotti M; Schwienbacher C; Ballerini G; Marchetti G
Hum Mol Genet; 1993 May; 2(5):545-8. PubMed ID: 8518792
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
4. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
[TBL] [Abstract][Full Text] [Related]
6. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.
Randi AM; Rabinowitz I; Mancuso DJ; Mannucci PM; Sadler JE
J Clin Invest; 1991 Apr; 87(4):1220-6. PubMed ID: 2010538
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
10. In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A.
Campioni M; Legendre P; Loubiere C; Lunghi B; Pinotti M; Christophe OD; Lenting PJ; Denis CV; Bernardi F; Casari C
J Thromb Haemost; 2021 Jan; 19(1):139-146. PubMed ID: 33047469
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
[TBL] [Abstract][Full Text] [Related]
12. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
Keeney S; Cumming A; Hay C
Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
[TBL] [Abstract][Full Text] [Related]
13. A novel Alu-mediated 61-kb deletion of the von Willebrand factor (VWF) gene whose breakpoints co-locate with putative matrix attachment regions.
Xie F; Wang X; Cooper DN; Chuzhanova N; Fang Y; Cai X; Wang Z; Wang H
Blood Cells Mol Dis; 2006; 36(3):385-91. PubMed ID: 16690331
[TBL] [Abstract][Full Text] [Related]
14. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.
O'Brien LA; James PD; Othman M; Berber E; Cameron C; Notley CR; Hegadorn CA; Sutherland JJ; Hough C; Rivard GE; O'Shaunessey D; Lillicrap D;
Blood; 2003 Jul; 102(2):549-57. PubMed ID: 12649144
[TBL] [Abstract][Full Text] [Related]
15. A 12.3-kb Duplication Within the
Lehner S; Ekhlasi-Hundrieser M; Detering C; Allerkamp H; Pfarrer C; von Depka Prondzinski M
G3 (Bethesda); 2018 Feb; 8(2):577-585. PubMed ID: 29208651
[TBL] [Abstract][Full Text] [Related]
16. The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
Randi AM; Sacchi E; Castaman GC; Rodeghiero F; Mannucci PM
Thromb Haemost; 1993 Feb; 69(2):173-6. PubMed ID: 8456430
[TBL] [Abstract][Full Text] [Related]
17. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
18. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
Lavergne JM; De Paillette L; Bahnak BR; Ribba AS; Fressinaud E; Meyer D; Pietu G
Br J Haematol; 1992 Sep; 82(1):66-72. PubMed ID: 1419804
[TBL] [Abstract][Full Text] [Related]
19. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
Michiels JJ; van Vliet HH
Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
